In addition, polymorphisms in the CYP2C19 gene have been reported to be positively associated with cardiovascular diseases, such as coronary artery disease and atherosclerosis (Ercan et al., 2008; Yang et al., 2010). This evidence concerns the gene CYP2C19 and atherosclerosis.